CoChat

The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome

Minozzi, Massimo, Costantino, Demetrio, Guaraldi, Claudia, Unfer, Vittorio · 2011 · Gynecological Endocrinology
Cited by 56

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

AIM: Compare the effects of a combined contraceptive pill (OCP) in combination with myo-inositol (MI) on endocrine, metabolic, and clinical parameters in patients with polycystic ovary syndrome (PCOS). METHODS: One hundred fifty-five patients with PCOS were enrolled in this prospective, open-label clinical study. Patients were assigned to receive oral treatment with OCP alone (estradiol (EE) 30 μg/gestodene 75 μg) or in combination with myo-inositol 4 g/die, for 12 months. RESULTS: OCP plus MI therapy resulted in a higher reduction of FG score compared with OCP alone therapy. The combined therapy (OCP plus MI) significantly decreased hyperinsulinaemia, by positively affecting the fasting insulin and glucose levels and homeostasis model assessment-insulin resistance parameters, while no significant changes were observed in the OCP group. Androgens serum levels decreased in both groups, but significantly more in the combined therapy group. The lipid profile was improved in the combined therapy group, by reducing low-density lipoprotein cholesterol levels and enhancing high-density lipoprotein cholesterol levels. CONCLUSIONS: Our data show that a combination of combined contraceptive pill and MI may be more effective in controlling endocrine, metabolic, and clinical profile in patients with PCOS than OCP alone, and may reduce insulin levels and insulin resistance. Hence, combined treatment may become a more effective long-term therapeutic choice for controlling PCOS symptoms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/09513590.2011.564685

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 30

  1. Asuncion M, 2000, J Clin Endocrinol Metab, 85, 2434
  2. Diamanti-Kandarakis E, 2006, Endocrinol Nutr, 53, 25, 10.1016/S1575-0922(06)71062-2 · DOI
  3. Escobar-Morreale HF, 2005, Endocr Rev, 26, 251, 10.1210/er.2004-0004 · DOI · Paper page
  4. Gambineri A, 2006, Endocrinol Nutr, 53, 49
  5. Alvarez-Blasco F, 2006, Arch Intern Med, 166, 2081, 10.1001/archinte.166.19.2081 · DOI · Paper page
  6. Dunaif A, 1997, Endocr Rev, 18, 774
  7. Utiger RD, 1996, N Engl J Med, 335, 657, 10.1056/NEJM199608293350909 · DOI · Paper page
  8. Apridonidze T, 2005, J Clin Endocrinol Metab, 90, 1929, 10.1210/jc.2004-1045 · DOI · Paper page
  9. Cattrall FR, 2004, Best Pract Res Clin Obstet Gynaecol, 18, 803, 10.1016/j.bpobgyn.2004.05.005 · DOI
  10. Dejager S, 2001, Clin Endocrinol (Oxf), 54, 455, 10.1046/j.1365-2265.2001.01245.x · DOI · Paper page
  11. Castelo-Branco C, Gynecol Endocrinol, 26, 736, 10.3109/09513590.2010.481025 · DOI · Paper page
  12. Hardiman P, 2003, Lancet, 361, 1810, 10.1016/S0140-6736(03)13409-5 · DOI · Paper page
  13. Speroff L, 2005, Clinical gynecologic endocrinology and infertility
  14. 10.2165/00003495-200464210-00006 · DOI
  15. Harborne L, 2003, Lancet, 361, 1894, 10.1016/S0140-6736(03)13493-9 · DOI · Paper page
  16. 10.1097/00003081-200306000-00011 · DOI · Paper page
  17. Baillargeon JP, 2008, Hum Reprod, 23, 1439, 10.1093/humrep/den097 · DOI · Paper page
  18. 10.2337/diacare.29.02.06.dc05-1070 · DOI · Paper page
  19. Nestler JE, 1997, J Clin Endocrinol Metab, 82, 4075
  20. Minozzi M, 2008, Reprod Biomed Online, 17, 579, 10.1016/S1472-6483(10)60248-9 · DOI
  21. 10.1080/09513590701672405 · DOI · Paper page
  22. Costantino D, 2009, Eur Rev Med Pharmacol Sci, 13, 105
  23. 2004, Fertil Steril, 81, 19
  24. 10.1210/jc.2002-021528 · DOI · Paper page
  25. Frempong BA, 2008, J Clin Endocrinol Metab, 93, 2097, 10.1210/jc.2007-2599 · DOI · Paper page
  26. van Rooijen M, 2002, Am J Obstet Gynecol, 186, 44, 10.1067/mob.2002.119179 · DOI
  27. Ferriman D, 1961, J Clin Endocrinol Metab, 21, 1440, 10.1210/jcem-21-11-1440 · DOI · Paper page
  28. 10.1080/09513590903015544 · DOI · Paper page
  29. Rajkhowa M, 1997, J Clin Endocrinol Metab, 82, 3389
  30. Tornvall P, 1996, Metabolism, 45, 1375, 10.1016/S0026-0495(96)90118-3 · DOI

Cited by

See all 56

Metadata

Authors
Minozzi, M., Costantino, D., Guaraldi, C., & Unfer, V.
Venue
Gynecological Endocrinology
Published
2011-03-21
Volume
27
Issue
11
Pages
920-924
ISSN
  • 0951-3590 (ISSN-L)
  • 1473-0766
OpenAlex
W2056107937
Cited by
56
References
9
FWCI
2.25
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome. https://app.cochat.ai/papers/10.3109/09513590.2011.564685
The paper
Minozzi, M., Costantino, D., Guaraldi, C., & Unfer, V. (2011). The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome. Gynecological Endocrinology. https://doi.org/10.3109/09513590.2011.564685

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.